Abstracts The diagnostic yield of various tests for Helicobacter pylori infection in patients on acid-reducing drugs, such as proton pump inhibitors (PPI) and histamine-2 receptor blocker (H2RB), was compared. Seventy-four consecutive patients on acid-reducing drugs were enrolled: 34 (46%) were on PPIs, 20 (27%) were on H2RBs and 20 (27%) were not on medications. For those patients on PPIs, RUT and histology results from antrum were negative in 28 (82%) and 17 (50%) patients, respectively (OR: 4.7; 95% CI: 1.4-16.6; P = 0.004), while those from the corpus were negative in was 28 (82%) and 18 (53%) patients, respectively (OR: 4.4, 95% CI: 1.3-15.5; P = 0.006). For patients on H2RBs, RUT and histology results from the antrum were negative in 12 (60%) and six (30%) patients, respectively (OR: 3.5; 95% CI: 0.8-16.1; P = 0.05), while those from the corpus were negative in 12 (60%) and nine (45%) patients, respectively (OR: 1.8; 95% CI: 0.4-7.8; P = 0.342). For those patients on PPIs, the diagnostic yield of both RUT and histology was reduced from both the antrum and corpus. In these patients, PCR for H. pylori is more sensitive than RUT and histology.
Introduction
All patients with Helicobacter pylori infection and peptic ulcer disease require treatment with antibiotics and acidreducing drugs, such as proton pump inhibitors (PPIs; such as omeprazole) or histamine-2 (H 2 ) receptor blockers (H2RBs) [1] . A variety of techniques are available for the diagnosis of active H. pylori infection, including the rapid urease test (RUT), the 13 C urea breath test and stool antigen testing [2, 3] . The urease produced by H. pylori catalyzes the hydrolysis of urea to yield a high local concentration of ammonia that serves as the basis of diagnostic tests for the presence of the H. pylori organisms in the rapid urease biopsy test and 13 C urea breath test. The urease activity of H. pylori is indicated by a color change -from yellow to pink -with the introduction of the gastric biopsy. RUTs are widely used at endoscopy to determine the presence of H. pylori based on the production urease, and the Maastricht 2-2000 Consensus Report recommends that retesting should be offered to all patients after H. pylori eradication therapy [1] . This should be carried out 4 weeks after the completion of therapy and preferably when the patient is off all acidreducing drugs since recent use of the latter can cause falsenegative results with either of the two active tests [1] .
In our practice, the rapid urease biopsy test and histology are the two methods commonly employed to confirm the presence of H. pylori infection. The RUT commonly used is the Pronto Dry (Medical Instrument Corp, Solothum, Switzerland) as it has the advantage of rapid results, storage at room temperature for 2 years and simple use at room temperature [4] . Locally, some of the gastroenterologists prefer histology to rule out H. pylori infection in preference to RUT. Histological analyses have the dual advantage that an additional report is handed over to the patient that documents the presence or absence of H. pylori infection, and concrete histological results help reassure patients.
PPIs have become one of the world's most frequently prescribed medications, [5] , and they are much cheaper than H2RBs in Pakistan where self-prescription is common and medications are available over the counter at pharmacies without prescriptions [6] . In a previous study we demonstrated that the sensitivity, specificity, negative predictive value and positive predictive value of the RUT was reduced in patients who were on PPIs [7] . The aim of this study was to compare the diagnostic yield of Pronto Dry and histology with 16S PCR for H. pylori infection in patients on PPIs and H2RBs. We used 16S PCR due to its higher diagnostic yield compared to histology, as shown in a previous study [8] . However, 16S PCR is not a costeffective diagnostic tool as there is a high sero-prevalence of H. pylori in the population of Pakistan [9] .
.
Materials and methods

Patients
Seventy-four patients with dyspepsia attending the endoscopy suite from February 2005-January 2006 were enrolled in this study. Patients were assigned into three groups: those who received PPIs (1) or H2RBs (2) in the 4 weeks preceding the study period and (3) patients with no previous treatment with antibiotics, PPIs, H2RBs and bismuth compounds in the same 4-week period. The PPI used by the patients was omeprazole 20 mg twice a day or ranitidine 150 mg twice daily for 4 weeks. Based on selfreport, the patients showed good compliance with both medications. The clinical symptoms at the time of presentation, diagnosis, drug treatment dosage and duration were noted together with the endoscopic findings. Patients who were previously treated for H. pylori infection in the last 3 months or who had recently received antibiotics within the last 8 weeks were excluded. Informed consent was obtained for esophagogastroduodenoscopy (EGD) and for additional biopsies from the antrum and body of the stomach in all the patients. The study was approved by the Ethics Review Committee of Aga Khan University Hospital. EGDs were performed after an 8-h fast. After each examination, the endoscopes were washed with detergent and disinfected with 70% ethanol followed by rinsing with sterile water. Biopsy forceps were sterilized by autoclaving. All patients received conscious sedation with intravenous midazolam and topical pharyngeal anesthetic spray. Sterilized biopsy forceps were used to obtain gastric biopsy specimens from an area of inflammation in the antrum and corpus within 2 cm of the pylorus and mid-body of the corpus. Two biopsy specimens were obtained using biopsy forceps for each of the Pronto Dry, histology and PCR analyses. The biopsy specimens were then removed from the biopsy forceps with a sterile needle, and two were inserted into the Pronto Dry analysis system, two were placed in formalin for the histology analyses and two were placed in 0.9% normal saline for the 16S PCR analysis.
Urease test
Pronto Dry results were read in 30 min after sampling, in accordance with the manufacturer's instructions. The color change from yellow to pink was considered to indicate the presence of urease.
Histology
Two gastric antral and body biopsy specimens for histopathology were stained with hematoxylin and eosin stain for the detection of H. pylori and degree of gastritis. In doubtful cases, Giemsa staining was carried out to ascertain the presence of H. pylori. The degree of gastritis as determined by the degree of hematoxylin and eosin (H&E) staining was scored in accordance with the Sydney system [10] .
PCR for H. pylori 16S rRNA
Tissue DNA extraction DNA was extracted from gastric tissue as described by Van Zwet et al. [11] . Briefly, gastric tissue was homogenized to uniformity in 500 ll of sterile water and centrifuged at 12,000 · g for 3 min. The supernatant was removed and about 500 ll of lysis buffer (100 mM NaCl, 10 mM TrisHCl, pH 8.0, 25 mM EDTA, 0.5% sodium dodecyl sulfate) and 10 ll of proteinase K (10 mg/ml) was added to the pellet, followed by incubation at 50°C for 20 h, phenolchloroform extraction and ethanol precipitation. The resulting pellet was allowed to dissolve in 40 ll of TE buffer (10 mM Tris-HCl, pH 7.4) and 0.1 mM EDTA (pH 8.0) for 20 h at 37°C. Samples were stored at -20°C before PCR amplification was performed. DNA content and purity was determined by measuring the absorbance at 260 nm and 280 nm using a spectrophotometer (Beckman DU-600, USA).
PCR amplification
PCR was performed using extracted DNA as the template and Helicobacter-specific16S rRNA gene primers C97 (5¢-GCT ATG ACG GGT ATC C-3¢; 276-291 forward) and C98 (5¢-GAT TTT ACC CCT ACA CCA-3¢; 681-698 reverse) to amplify the amplicon of approximately 400 bp as described previously [12] . The PCR amplification was carried out in a total volume of 50 ll containing 2 ll of 2 mM dNTPs, 1 ll of 25 qmol of primer C97, 1 ll of 25 qmol of primer C 98 (synthesized by an MGW Automatic Synthesizer), 2 U Taq DNA polymerase (Promega, Madison, Wis.), 5 ll of 10· PCR reaction buffer (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 0.1% Triton-X-100 after dilution), 3 mM MgCl 2 , 1 ll DNA template containing 0.5 ng of extracted DNA; the total volume was rounded up to 50 ll by the addition of double-distilled water. The reaction was carried out in a Perkin Elmer thermal cycler (model 480; Foster City, Calif.). The amplification cycle consisted of an initial denaturation of target DNA at 94°C for 5 min, followed by denaturation at 94°C for 1 min, primer annealing at 55°C for 1 min and extension at 72°C for 1 min and 30 s. The final cycle included an extension step of 5 min at 72°C to ensure full extension of the product. Samples were amplified through 35 consecutive cycles. Helicobacter pylori ATCC 49503 genomic DNA was used as a positive control, while double-distilled water was used for negative control reactions with each batch of amplifications. Aliquots (8 ll) of the amplified PCR products were analyzed on a 2% (wt/vol) agarose gel; the electrophoresis products were stained with ethidium bromide and observed under short-wavelength ultraviolet light.
A diagnosis of H. pylori infection was made when the results from the 16S PCR and RUT or histology were positive. A negative diagnosis of H. pylori was made when the results of the 16S PCR and RUT or histology on the antral biopsies were negative.
Statistical assessment
The Statistical Package for Social Science SPSS (Release 10.0.5, standard version; SPSS, Chicago, Ill.) was used for data analysis. The descriptive analysis was carried out on the demographic and clinical features. The results are presented as the mean ± standard deviation for the quantitative variables and as numbers (and percentages) for the qualitative variables. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated to check the strength of association. Sensitivity, specificity and positive and negative predictive values were determined for RUT and histology. The power of the study to compare the diagnostic yield of PCR, RUT and histology for detecting H. pylori infection in patients on PPI and H2RB was 80%.
Results
The patient cohort consisted of 74 patients ranging in age from 20 to 76 years (mean age: 42 ± 14.2 years) of whom 48 (65%) were male and 26 (35%) were female. Thirtyfour (46%) patients were on PPIs, 20 (27%) were on H2RBs and 20 (27%) were not on medications. The presenting symptoms were abdominal pain in 73 (99%) patients, nausea in nine (13.5%) patients and heart burn in one (1%) patient. The main endoscopic findings were antral gastritis (69 patients; 93%), reflux esophagitis (two patients; 3%), hiatus hernia (two patients; 3%) and gastric ulcer (one patient; 1%). The histology analyses revealed H. pylori-associated mild-moderate gastritis in 43 patients (58%) and H. pylori-negative mild non-specific gastritis in 31 patients (42%).
Patients on PPIs
For those patients on PPIs, the results from the RUT and histology on the antrum were negative in 28 (82%) and 17 (50%) patients, respectively (OR: 4.7; 95% CI: 1.4-16.6; P = 0.004), while those from the same analyses on the corpus were negative in 28 (82%) and 18 (53%) patients, respectively (OR: 4.4; 95% CI: 1.3-15.5; P = 0.006) (Table 1, treatment 5). The diagnostic yield of PCR was similar from specimens from both the antrum (25 patients; 74%) and body (24 patients; 71%) (OR: 1.2; 95% CI: 0.4-3.3; P = 0.787) ( Table 1 , treatment 1). The diagnostic yield of RUT was reduced to 6 patients in both the antrum (18%) and corpus (18%) (OR: 1; 95% CI: 0.3-3.5; P = 0.999). Also, the histology from the antrum was positive in 17 (50%) patients and from the corpus, 16(47%) patients (OR: 1.1; 95% CI: 0.4-2.9; P = 0.808) ( Table 1 , treatment 1).
Patients on H 2 -receptor blockers
In H2RB patients, the RUT and histology results from the antrum were negative in 12 (60%) and six (30%) patients, respectively (OR: 3.5 95%; CI: 0.8-16.1; P = 0.05); negative results from the corpus were obtained in 12 (60%) and nine (45%) patients, respectively (OR: 1.8; 95% CI: 0.4-7.8; P = 0.342) ( Table 1) .
No treatment group
In this group, the RUT and histology results from the antrum were negative in nine (45%) and 11 (55%) patients, respectively (OR: 0.7; 95% CI: 0.2-2.8; P = 0.527), while negative results from the corpus were obtained for eight 8 (40) and 12 (60) patients, respectively (OR 2.3; 95% CI: 0.5-9.8; P = 0.205) ( Table 1 , treatment 5). The diagnostic yield of PCR was greater from the antrum (15 patients; 75%) than from the corpus (11 patients; 55%) (OR: 2.5; 95% CI: 0.6-9.4; P = 0.19) ( 
Comparison of the RUT and histology with PCR
The sensitivity and specificity of the RUT and histology analyses was 39 and 80%, and 57.4 and 55%, respectively, from the antrum; for the corpus, these were 43.1 and 82.6%, and 55 and 69.6%, respectively. The sensitivity, negative predictive value (NPV) and accuracy of the RUT from both the antrum and corpus were lower than those of the PCR analyses ( Table 2 ). The likelihood of a positive RUT and histology from the body was 2.5 and 1.8, respectively, as compared to 1.9 and 1.3 from the antrum ( Table 2 ). The PCR analysis was equally sensitive from both the antrum and body, with similar NPV, accuracy and positive and negative likelihood ratio ( Table 2 ).
Discussion
The PPI produces a greater decrease in gastric acid secretion than H2RB in subjects with H. pylori infection [13] . H2RBs are effective for the long-term prevention of recurrences of peptic ulcer diseases, although the efficacy of H2RBs is still lower than that of PPIs [14, 15] . In this study, the diagnostic yield of PCR on gastric tissue was higher than that of RUT and histology in patients with H. pylori infection on PPI and H2RB medication. The RUT had a reduced diagnostic yield compared to 16S PCR and histology in the presence of a prior use of acid-reducing drugs (Table 1) . PPIs affected RUT negatively by 82% negative compared to 50% with histology (OR: 1.0 95%; CI: 0.3-3.5; P = 0.9) ( Table 1 ). The effect of PPI on histology was greater than that ofH2RB (Table 1). In the presence of prior use of H2RB, histology had a better yield from both sites compared to RUT (Table 1 ). In the no treatment group, RUT had a better yield than histology ( Table 1) . The slightly lower yield of histology in this group might be explained by the biopsy specimen containing a low bacterial density of viable cells, thereby leading to the failure to identify H. pylori and thus resulting in false negatives.
The implications of this study are that with prior use of PPI, RUT from the antrum is not the test to be used for the diagnosis of H. pylori infection. RUT sensitivity was reduced to 39% compared to PCR from antrum, while histology had a better sensitivity of 57.4% from the antrum (Table 2) . Overall, PCR and histology yielded positive results more often from the antrum than from the body. However, this difference did not reach statistical significance due to the small number of patients in this study (Table 1) . However, power analysis of the study was 80%. Logan et al. [16] found that during treatment with a PPI, the distribution of H. pylori within the stomach changes so that the density in the antrum is reduced and that in the corpus is relatively increased. However, Graham et al. [17] believe that PPIs are detrimental to H. pylori at both the antrum and corpus. Our results are consistent with those of this latter study (Table 1). In an earlier study using the CLO test, a RUT on a single antral biopsy had a sensitivity of 97% in 35 patients not on antisecretory medication, 76% in 34 patients on an H2RB and 41% in 12 patients on a PPI, while the sensitivity of histological evaluation in the same groups was 91, 91 and 75%, respectively [18] . Also, in this same study, histology from the corpus biopsies was more reliable, with a sensitivity of 83% in patients on a PPI, 91% in patients on an H2RB and 94% in patients not taking an antisecretory drug [18] . However, in contrast, the histological assessment of antral biopsies in our study appears to be more affected in patients on PPIs and less effected in those taking H2RB. Our results are consistent with those of previous studies indicating that a negative RUT result from an antral biopsy in patients taking PPIs or H2RBs is insufficient evidence of the absence of H. pylori infection. As the number of patients in each group were small in our study, it is difficult to recommend routine histological assessment in patients on acid-reducing drugs. Hopefully, an ongoing randomized controlled study will answer this question in the future. If there is a possibility that RUT will be negative or inconclusive, then histology can be undertaken. In addition to documenting the presence of the organism, histology allows the underlying gastritis to be evaluated. In the absence of chronic inflammation, H. pylori infection can be reliably excluded [19] . However, biopsies are usually not done purely to identify H. pylori [19] . Ideally, patients should not be taking an acid-reducing drug at the time of endoscopy if a biopsy urease test is to be used as the sole method for determining H. pylori status.
Based on these results, we conclude that when an endoscopy is indicated in a patient on PPIs or H2RBs, the test of choice for H. pylori infection is not a RUT on an antral biopsy. Biopsies should preferably be carried out for both RUT and histology.
